FDA Relaxes Restrictions on Live Vaccine Processing
Executive Summary
Manufacturers of live vaccines such as those for influenza will soon be able to rely solely on process controls and, where necessary, process containment, to prevent cross-contamination of live vaccine organisms, under a recent direct final rule by FDA